Abstract: The present invention relates to compounds useful as inhibitors of voltage-gated ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
Type:
Grant
Filed:
July 2, 2004
Date of Patent:
October 19, 2010
Assignee:
Vertex Pharmaceuticals Incorporated
Inventors:
Dean Mitchell Wilson, Esther Martinborough, Timothy Donald Neubert, Andreas Peter Termin, Jesus E. Gonzalez, III, Nicole Zimmerman
Abstract: The present invention relates to compounds useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
Type:
Grant
Filed:
May 15, 2006
Date of Patent:
April 27, 2010
Assignee:
Vertex Pharmaceuticals Incorporated
Inventors:
Andreas Termin, Dean Wilson, Lev T. D. Fanning, Paul Krenitsky, Pramod Joshi
Abstract: The present invention relates to compounds of Formula I: or a pharmaceutically acceptable salt thereof, wherein the R1, Z, Y, RA, and W groups of formula I are as defined herein. The invention also provides pharmaceutically acceptable compositions and methods of using the compositions in the treatment of various disorders.
Type:
Grant
Filed:
November 1, 2007
Date of Patent:
April 27, 2010
Assignee:
Vertex Pharmaceuticals Incorporated
Inventors:
Dean M. Wilson, Andreas P. Termin, Jesus E. Gonzalez, III, Nicole Zimmermann, Yulian Zhang, Lev T. D. Fanning
Abstract: The present invention relates to compounds useful as inhibitors of voltage-gated sodium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
Type:
Grant
Filed:
May 4, 2006
Date of Patent:
March 23, 2010
Assignee:
Vertex Pharmaceuticals Incorporated
Inventors:
Dean Wilson, Andreas Termin, Dewey Fanning, Paul Krenitsky, Pramod Joshi
Abstract: Heterocyclic derivatives act as Ca channel antagonists. The compositions are useful for treating or relieving Ca channel mediated conditions.
Type:
Grant
Filed:
June 22, 2005
Date of Patent:
August 4, 2009
Assignee:
Vertex Pharmaceuticals Incorporated
Inventors:
Andreas Termin, Esther Martinborough, Nicole Zimmerman, Charles Cohen, Corey Gutierrez